Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Cornelius Cathcart

Pediatrics Henderson, NC Medical Doctor

NPI 1235194671 CMS profile 283150

451 Ruin Creek Rd, Suite 101, Henderson, NC 27536

Open in the dashboard

General payments

$3,398

159 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Cornelius Cathcart of Henderson, NC is reported in the CMS Open Payments database as having received $3,398 across 159 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $15 1
2024 General $485 21
2023 General $637 38
2022 General $922 42
2021 General $481 22
2020 General $253 15
2019 General $605 20

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Cornelius Cathcart
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to Cornelius Cathcart were reported at $15. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year Cornelius Cathcart Pediatrics median Middle half National median
2019 $605 $86 $31–$183 $163
2020 $253 $49 $22–$110 $114
2021 $481 $68 $27–$158 $132
2022 $922 $77 $30–$173 $149
2023 $637 $88 $33–$190 $160
2024 $485 $94 $34–$206 $164
2025 $15 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Ironshore Pharmaceuticals Inc. $901 48 payments
  2. Supernus Pharmaceuticals, Inc. $858 35 payments
  3. Corium, Inc. $551 19 payments
  4. Tris Pharma Inc $440 21 payments
  5. Adlon Therapeutics L.P. $152 11 payments
  6. Takeda Pharmaceuticals U.S.A., Inc. $130 5 payments
  7. Neos Therapeutics, LP $82 6 payments
  8. Pfizer Inc. $82 3 payments
  9. Sanofi Pasteur Inc. $57 3 payments
  10. Baxter Healthcare $34 1 payment
  11. Other $110 7 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,364 158 payments
  2. Long term medical supply or device loan $34 1 payment
Products named General payments · program years 2019–2025
  1. QELBREE Psychology $696 31 payments
  2. Azstarys $551 19 payments
  3. Jornay PM 20mg capsules (Bottle of 100) $397 8 payments
  4. JORNAY PM Central Nervous System Stimulant $303 24 payments
  5. JORNAY PM Central Nervous Stimulant ADHD $201 16 payments
  6. Dyanavel XR $183 8 payments
  7. ADHANSIA XR $152 11 payments
  8. Qelbree Viloxazine Hydrochloride $147 3 payments
  9. VYVANSE $141 6 payments
  10. Quillivant $81 4 payments
  11. Other $729 42 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

159 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatrics in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record